English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis Journal article
Wang, Anqi, Liu, Yuanyuan, Xiong, Wugui, Li, Wei, Li, Jin, Yang, Zhiqiang, Zou, Zhongtao, Luo, Yinjia, Chen, Zhoujiang, Li, Hanmei, Vong, Chi Teng, Zou, Liang. Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis[J]. Journal of Pharmaceutical Sciences, 2024, 113(9), 2744-2755.
Authors:  Wang, Anqi;  Liu, Yuanyuan;  Xiong, Wugui;  Li, Wei;  Li, Jin; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.7/3.5 | Submit date：2024/08/05
Ulcerative Colitis  Honokiol  Colonic Targeting  Inflammation  D-galactose  
An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease Journal article
Huang Z., Gan J., Jia L., Guo G., Wang C., Zang Y., Ding Z., Chen J., Zhang J., Dong L.. An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease[J]. Biomaterials, 2015, 48, 26.
Authors:  Huang Z.;  Gan J.;  Jia L.;  Guo G.;  Wang C.; et al.
Favorite | TC[WOS]:63 TC[Scopus]:72 | Submit date：2018/10/30
Antisense Oligonucleotide  Colonic Macrophages  Inflammatory Bowel Disease  Targeting Delivery  Tnf-α